Money Concepts Capital’s Definium Therapeutics DFTX Stock Holding History

Money Concepts Capital’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$612K	Hold	13,000	–	–	0.03%	386
2026 Q1	$246K	Hold	13,000	–	–	0.01%	501
2025 Q4	$174K	Hold	13,000	–	–	0.01%	509
2025 Q3	$153K	Buy	+13,000	New	+$121K	0.01%	460
2023 Q1	–	Sell	-500	Closed	-$1.1K	–	1946
2022 Q4	$1.1K	Buy	+500	New	+$1.39K	﹤0.01%	2858

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Money Concepts Capital's DFTX Position: Q2 2026 in Review

Money Concepts Capital held its Definium Therapeutics (DFTX) position steady in Q2 2026 at 13,000 shares worth $612K. The position accounts for 0.03% of the portfolio, ranked #386.

Money Concepts Capital first reported a position in DFTX in Q4 2022 and has held it in 5 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Money Concepts Capital held 13,000 shares of Definium Therapeutics worth $612K as of Q2 2026.
Money Concepts Capital left its Definium Therapeutics share count unchanged in Q2 2026.
Definium Therapeutics made up 0.03% of Money Concepts Capital's portfolio in Q2 2026, its #386 holding.
Money Concepts Capital first reported a position in Definium Therapeutics in Q4 2022 and has held it in 5 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Money Concepts Capital's 13F filing for Q2 2026, filed 4 Aug 2026.